Cholestenone 5 alpha-Reductase
"Cholestenone 5 alpha-Reductase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oxidoreductase that catalyzes the conversion of 3-oxo-delta4 steroids into their corresponding 5alpha form. It plays an important role in the conversion of TESTOSTERONE into DIHYDROTESTOSTERONE and PROGESTERONE into DIHYDROPROGESTERONE.
Descriptor ID |
D042944
|
MeSH Number(s) |
D08.811.682.660.200
|
Concept/Terms |
Cholestenone 5 alpha-Reductase- Cholestenone 5 alpha-Reductase
- 5 alpha-Reductase, Cholestenone
- Cholestenone 5 alpha Reductase
- alpha-Reductase, Cholestenone 5
- 4-Ene Steroid 5 alpha-Reductase
- 4 Ene Steroid 5 alpha Reductase
- 5 alpha-Reductase
- 5 alpha Reductase
|
Below are MeSH descriptors whose meaning is more general than "Cholestenone 5 alpha-Reductase".
Below are MeSH descriptors whose meaning is more specific than "Cholestenone 5 alpha-Reductase".
This graph shows the total number of publications written about "Cholestenone 5 alpha-Reductase" by people in this website by year, and whether "Cholestenone 5 alpha-Reductase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholestenone 5 alpha-Reductase" by people in Profiles.
-
Djavan B, Eastham J, Gomella L, Tombal B, Taneja S, Dianat SS, Kazzazi A, Shore N, Abrahamsson PA, Cheetham P, Moul J, Lepor H, Crawford ED. Testosterone in prostate cancer: the Bethesda consensus. BJU Int. 2012 Aug; 110(3):344-52.
-
Zeigler-Johnson CM, Walker AH, Mancke B, Spangler E, Jalloh M, McBride S, Deitz A, Malkowicz SB, Ofori-Adjei D, Gueye SM, Rebbeck TR. Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4. Hum Hered. 2002; 54(1):13-21.